Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Virax Biolabs Group Limited (VRAX) Weighted-Average Shares Outstanding (Diluted) data is not available.
Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
Weighted-Average Shares Outstanding (Diluted) |
-- |
-- |
|
-- |
|
Balance Sheet Financials | |
$8.03M |
|
$1.05M |
|
$1.41M |
|
$9.44M |
|
$0.69M |
|
-- |
|
$0.33M |
|
$1.03M |
|
$8.42M |
|
$8.42M |
|
$8.42M |
|
4.34M |
|
Cash Flow Statement Financials | |
$-1.92M |
|
$-0.25M |
|
$5.86M |
|
$3.59M |
|
$7.29M |
|
$3.70M |
|
$0.04M |
|
-- |
|
-- |
|
Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |